2023
DOI: 10.3390/gels9030198
|View full text |Cite
|
Sign up to set email alerts
|

Design and Evaluation of Paeonol-Loaded Liposomes in Thermoreversible Gels for Atopic Dermatitis

Abstract: Paeonol (PAE) is a hydrophobic drug. In this study, we encapsulated paeonol in a lipid bilayer of liposomes (PAE-L), which delayed drug release and increased drug solubility. When PAE-L was dispersed in gels (PAE-L-G) based on a poloxamer matrix material for local transdermal delivery, we observed amphiphilicity, reversible thermal responsiveness, and micellar self-assembly behavior. These gels can be used for atopic dermatitis (AD), an inflammatory skin disease, to change the surface temperature of the skin. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 69 publications
0
0
0
Order By: Relevance
“…This release behavior was mainly due to T-Lip-AC not only passing through the lipid bilayer, but also through the three-dimensional network structure of ALG-CS. [40] The ultimate maximum release of T-AC in the first stage was due to its rapid release and adsorption onto the surface of ALG-CS, and the threedimensional network structure of ALG-CS extended the drug release time. The second stage, which extends from 24 h to 96 h, was achieved through a diffusion mechanism and resulted in prolonged drug release due to the slow dissolution and dispersion of the threedimensional network structure of the lipid core matrix and ALG-CS.…”
Section: Discussionmentioning
confidence: 98%
“…This release behavior was mainly due to T-Lip-AC not only passing through the lipid bilayer, but also through the three-dimensional network structure of ALG-CS. [40] The ultimate maximum release of T-AC in the first stage was due to its rapid release and adsorption onto the surface of ALG-CS, and the threedimensional network structure of ALG-CS extended the drug release time. The second stage, which extends from 24 h to 96 h, was achieved through a diffusion mechanism and resulted in prolonged drug release due to the slow dissolution and dispersion of the threedimensional network structure of the lipid core matrix and ALG-CS.…”
Section: Discussionmentioning
confidence: 98%